
USFDA APPLICATION NUMBER - 20519 / DOSAGE - GEL;TOPICAL - 0.77% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| Ciclopirox(UNII: 19W019ZDRJ) (Ciclopirox - UNII:19W019ZDRJ) | Ciclopirox | 7.7mg in 1 |
Inactive Ingredients
| Ingredient Name | Alvogen Inc. |
|---|---|
| Carbomer Homopolymer Type C (Allyl Pentaerythritol Crosslinked)(4Q93RCW27E) | |
| Docusate Sodium(F05Q2T2JA0) | |
| Isopropyl Alcohol(ND2M416302) | |
| Octyldodecanol(461N1O614Y) | |
| Peg/Ppg-18/18 Dimethicone(9H0AO7T794) | |
| Sodium Hydroxide(55X04QC32I) | |
| Water(059QF0KO0R) |